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Annexin A2 is a multifunctional Ca2+- and lipid-binding protein. We previously showed that a distinct pool of cellular Annexin A2 associates
with mRNP complexes or polysomes associated with the cytoskeleton. Here we report in vitro and in vivo experiments showing that Annexin A2
present in this subset of mRNP complexes interacts with its cognate mRNA and c-myc mRNA, but not with β2-microglobulin mRNA translated
on membrane-bound polysomes. The protein recognises sequence elements within the untranslated regions, but not within the coding region, of its
cognate mRNA. Alignment of the Annexin A2-binding 3′-untranslated regions of annexin A2 mRNA from several species reveals a five
nucleotide consensus sequence 5′-AA(C/G)(A/U)G. The Annexin A2-interacting region of the 3′-untranslated region can be mapped to a
sequence of about 100 nucleotides containing two repeats of the consensus sequence. The binding elements appear to involve both single and
double stranded regions, indicating that a specific higher order mRNA structure is required for binding to Annexin A2. We suggest that this type of
interaction is representative for a group of mRNAs translated on cytoskeleton-bound polysomes.
© 2006 Elsevier B.V. All rights reserved.Keywords: Annexin A2; mRNA; 3′-UTR; mRNA-binding; consensus sequence; c-myc1. Introduction
In eukaryotic cells mRNA-binding proteins modulate gene
expression by regulating the activity, abundance and stability of
both the coding and non-coding mRNAs present in mRNP
complexes. These proteins contribute to the organisation of
mRNAs into structurally and functionally related subsets of such
complexes, thus coordinating mRNA localisation and the
synthesis of proteins involved in complex cellular processesAbbreviations: AnxA2, Annexin A2 protein; anxA2, annexin A2 mRNA or
cDNA; AnxA2t, Annexin A2 heterotetramer (AnxA22p112); BSA, bovine
serum albumin; CBP, cytoskeleton-bound polysomes; CDR, coding region; ds,
double stranded; FL, full-length; FP, free polysomes; HC, heavy chain; MBP,
membrane-bound polysomes; mRNP, messenger ribonucleotide particle; nt,
nucleotides; PCR, polymerase chain reaction; RAM, rabbit anti-mouse IgG; RT-
PCR, reverse trancriptase PCR; ss, single stranded; TEV, Tobacco Etch Virus;
UTR, untranslated region
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doi:10.1016/j.bbamcr.2006.08.043[1–4]. Most of the localised mRNAs require components of the
cytoskeleton for their transport from the nucleus to specific target
sites in the cell. Both actin filaments and microtubules, and their
associated motor molecules, play a role in mRNA targeting. In
general, the targeting signal resides in the 3′-UTRs of the
mRNAs. In the case of Vg1 and actin mRNAs, these elements
(also referred to as Zip codes) are small single stranded RNA
(ssRNA) sequences [5,6]. However, the precise targeting
sequences are often difficult to define since they are most likely
related to a higher order structure of the mRNAs. Accordingly,
secondary structures within cis-acting elements, in association
with trans-acting proteins, have been implicated in the targeting
of most mRNAs [7]. Different steps in the localisation of mRNAs
are often mediated by separate cis-acting elements. For example,
a sequence of 11 nucleotides (nt) is sufficient to direct the
transport of myelin basic protein mRNA from the cell body into
the oligodendrocyte processes, whereas another region of
approximately 340 nt, containing a stable secondary structure,
mediates its localisation to the myelin compartment [8].
Repression of translation during the transport process ensures
that protein expression occurs selectively at the target site [1]. For
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codes for the Nanos protein in Drosophila, is translated [9].
A 3′-UTR-binding protein, in complex with other proteins, is
involved in the targeting of β-actin mRNA to actin filaments in
fibroblasts [3,10]. A homologue of this protein targets Vg1
mRNA to microtubules in Xenopus oocytes [11]. Hence,
alternative filament-associated proteins appear to determine the
specificity of the association of distinct mRNAs with the
cytoskeleton. Annexin A2 (AnxA2) may function as such a
protein since it has been identified both as a F-actin-binding [12–
14] and a mRNA-binding protein [15–17], associated with a
specific subpopulation of mRNP complexes [15]. Interestingly,
regulation of mRNA-cytoskeleton interactions would only be one
of the cellular roles of this multifunctional protein, which has also
been implicated in signal transduction, membrane trafficking and
regulation of membrane/cytoskeleton contacts [18–22].
We have previously developed a method for the isolation of
three specific subpopulations of polysomes from cultured cells,
i.e. “free” (or loosely cytoskeleton-bound; FP), cytoskeleton-
bound (CBP) and membrane-bound polysomes (MBP) [23]. This
well-characterised fractionation protocol [15,24–29] made it
possible to analyse the compartmentalisation of specific mRNAs
and study their interactions with the cytoskeleton. As a result of
such analysis, AnxA2 was identified as a mRNA-binding protein
in the CBP fractions [15]. Since c-myc mRNA is translated on
CBP in Krebs II cells [24] and fibroblasts [25], the identity of the
components mediating the interaction of c-myc and other specific
mRNAs with the CBP was further studied. Here we show that
AnxA2 in mRNP complexes is associated with c-myc and anxA2
mRNAs translated on CBPs in vivo. Moreover, we provide
evidence supporting the conclusion that AnxA2 interacts with a
∼100 nt region in the 3′-UTR of its cognate mRNA.2. Materials and methods
2.1. Cell fractionation and isolation of polysomes
Three subpopulations of polysomes were isolated from Krebs II cells
essentially as described [23].
2.2. Northern blot analysis
Total RNA was isolated from each of the three individual polysomal
subpopulations purified from Krebs II cells by the single-step guanidinium–
isothiocyanate–phenol–chloroform extraction method [30]. The conditions for
Northern blotting were essentially as described by Hesketh et al. [25]. The probes
were generated from bovine anxA2 (corresponding to a sequence in the N-terminal
coding region with 86% homology to the same region in mouse anxA2), mouse c-
myc or β2-microglobulin cDNAs using Multiprime kits and R[α-
32P]dCTP
(3000 Ci/mmol), both obtained from Amersham Pharmacia Biotech.
2.3. Immunoprecipitation and reverse trancriptase polymerase chain
reaction (RT-PCR)
Immunoprecipitation of AnxA2–mRNP complexes was performed essen-
tially as published by Chu et al. [31]. In brief, Krebs II cells were fractionated as
described [23] and 1.5 mg of the cytoskeletal fraction was immunoprecipitated
using monoclonal AnxA2 antibodies (kindly provided by Prof. Volker Gerke,
Münster) coupled to protein A-Sepharose via rabbit anti-mouse IgG (RAM) after
pre-clearance by RAM. The immunoprecipitation was performed in NET-buffer(50 mM Tris–HCl, pH 7.4, 150 mM KCl and 0.05% Triton) containing 40 U/ml
of RNasin (Promega). The immunoprecipitates were phenol/chloroform
extracted twice. The first water-phase was incubated with RNase-free DNase
(Promega) before the second extraction. Nucleic acids were precipitated with
carrier tRNA and resuspended in RNase-free water. The interphase from the first
phenol/chloroform extraction was resuspended in NET-buffer and acetone
precipitated. AnxA2 was identified by Western blot analysis using monoclonal
AnxA2 antibodies (Transduction Laboratories). Next, immunoprecipitated RNA
was used as template for RT-PCR in the Access RT-PCR System (Promega) using
the conditions recommended by the manufacturer. 5 μMof primers (Eurogentec)
were used for the amplification of the 3′-UTRs of mouse c-myc, anxA2 and β2-
microglobulin cDNAs (Table 2A).
2.4. Purification of the AnxA2 heterotetramer (AnxA2t)
The AnxA2t was purified from epithelial cells derived from pig intestines as
described [12].
2.5. Construction of recombinant AnxA2
The bovine anxA2 cDNA, originally from the pcD vector (ac. no. M14056,
ATCC) [32], was cloned into the pGEM-3Zf(+) vector and used as a template for
the construction of recombinant AnxA2 by PCR. The PCR product was
synthesised using specific forward (5′-ATCCGGGAAGACTTCATGGG-
TATGTCTACCGTTCATGAAATTCTGTGC-3′) and reverse (5′-ATCCGG-
GAAGACTGGTACCTCAGTCATCCCCACCACACAGG-3′) primers
obtained from Eurogentec and TIB MOLBIOL. The PCR fragment was ligated
into the TOPO vector (Invitrogen) using TA cloning for amplification before
digestion by restriction enzymes (NcoI and Acc65I) and ligation of the PCR
product into the pETM-41 expression vector (kindly provided by Gunter Stier,
EMBL, Heidelberg). The vector is derived from the pET24d expression vector
(Novagen) and contains a 6His-Maltose Binding Protein tag followed by a
Tobacco Etch Virus (TEV)-protease sensitive linker (ENLYFQG). DNA
sequencing verified the identity of the final construct.
2.6. Protein expression and purification
The AnxA2 fusion protein (see above) was expressed overnight at 15 °C in
the BL-21 Escherichia coli strain. Cells were harvested by centrifugation and
resuspended in breakage buffer (50 mM Na2HPO4 (pH 8.0), 0.5 M NaCl,
10 mM imidazole, 5% (w/v) glycerol, 0.5 μg/ml DNase I, 0.25 μg/ml RNase A,
protease inhibitor cocktail (1 tablet/50 ml) (Complete, EDTA-free, Roche) and
1 mM DTT). Cells were disrupted by French press (type FA-073, SLM
Instruments). The homogenate was centrifuged at 100000 gav for 1 h at 4 °C,
and the supernatant was loaded on His-Select Nickel Affinity Gel (Sigma)
equilibrated with buffer A (50 mM Na2HPO4 (pH 8.0), 0.3 M NaCl and 10 mM
imidazole) and incubated for 1 h at 4 °C on a rotating wheel. The resin was
washed for 5 min with buffer A containing protease inhibitor cocktail (1 tablet/
100 ml), then 5 min with buffer B (50 mM Na2HPO4 (pH 8.0), 1 M NaCl,
10 mM imidazole and protease inhibitor cocktail (1 tablet/500 ml)) and finally
with buffer A containing protease inhibitor cocktail (1 tablet/500 ml) until the
A280 had reached approximately zero. The His-tagged protein was eluted from
the resin with buffer A containing 250 mM imidazole and protease inhibitor
cocktail (1 tablet/500 ml). 2 mM EGTAwas added to remove any traces of Ni2+
bound to the protein, and subsequently the eluted protein was immediately
loaded on a PD-10 column (Sephadex G-25, Pharmacia) equilibrated with
20 mM Tris, pH 8. The protein was digested with TEV protease at 4 °C (molar
ratio 1:50) during centrifugation at 480×g (overnight). Digested AnxA2 was
separated from the undigested form and from His-tagged Maltose Binding
Protein by loading it to Q-Sepharose (Amersham Biosciences) that had been
equilibrated overnight using 100 mM Tris (pH 8) and 500 mM NaCl. The resin
was washed twice in 100 mM Tris (pH 8) to remove the salt, before loading the
digestion mixture to the Q-Sepharose. Due to the difference in charge between
Maltose Binding Protein and AnxA2, the former binds to the Q-Sepharose while
AnxA2 remains unbound. The purity of recombinant AnxA2 was determined by
SDS-PAGE [33] followed by Coomassie Brilliant Blue staining and the
concentration was measured spectrophotometrically by using the theoretical
extinction coefficient at A280 of 30250 M
−1cm−1 as determined from the amino
Table 1
DNA templates used for the in vitro generation of different anxA2 transcripts
anxA2 transcript Restriction sites
for cloning
Linearised
by
Promoter
1–1381nt anxA2 (1) BamHI EcoRI SP6
Δ1–964nt anxA2 (2) BamHI–BglII BglII SP6
Δ55–1074nt anxA2 (3) BamHI–HindIII HindIII T7
Δ473–1381nt anxA2 (4) PstI–EcoRI EcoRI SP6
Δ473–964nt anxA2 (5) PstI–BglII BglII SP6
Δ1075–1381nt anxA2 (6) PstI–EcoRI EcoRI SP6
The respective anxA2 transcripts, the restriction enzyme sites used for cloning
and linearisation of the templates, and the RNA polymerases used for in vitro
transcription, are indicated. The numbers of the anxA2 transcripts in parenthesis
refer to the numbers of the transcripts shown in Fig. 3. The length and the
specific regions of the different anxA2 transcripts are shown in Fig. 3.
Fig. 1. The anxA2 mRNA associates with cytoskeleton-bound polysomes. The
distribution of anxA2, c-myc and β2-microglobulin mRNAs in RNA fractions
isolated from the “free” (loosely cytoskeleton-bound; FP), cytoskeleton-bound
(CBP) and membrane-bound (MBP) polysomes of Krebs II cells was
determined by Northern blotting. The resulting autoradiograms are shown.
20 μg of total RNA from each fraction was loaded on the gel.
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purified protein were stored in liquid N2.
2.7. Preparation of cDNA templates for in vitro transcription
The bovine anxA2 cDNA [32], cloned into the pGEM-3Zf(+) vector, was
used as a template for the construction of all the anxA2 transcripts. TranscriptsTable 2
Sequences of primers used in RT-PCR of AnxA2-immunprecipitated RNA in Fig. 2
A
Amplified fragment
Δ1095–1373nt anxA2
Δ1900–2265nt c-myc
Δ414–862nt β2-microglobulin
B
anxA2 transcript
Δ55–1074nt anxA2 (3)
3′UTR anxA2 transcripts
Δ1075–1381nt anxA2 (6)
Δ1075–1224nt anxA2 (7)
Δ1225–1381nt anxA2 (8)
Δ1075–1123nt anxA2 (9)
Δ1124–1224nt anxA2 (10)
Δ1075–1149nt anxA2 (11)
Δ1122–1143nt anxA2 (12)
Δ1150–1224nt anxA2 (13)
The length and specific regions of the different anxA2 transcripts are shown in Fig.2, 4 and 5 were excised directly from the anxA2 cDNA using the restriction sites
indicated in Table 1, while transcripts 3 and 6 were synthesised by PCR with
primers (Eurogentec) containing specific restriction sites (Tables 1 and 2B).
cDNAs of transcripts 1–6 were subcloned into the appropriate sites of the
pGEM3Zf+vector. All constructs were sequenced in both directions to verify
the orientation and sequences of the inserts. Transcripts 7–13 were all(A) and PCR of different anxA2 transcripts in Fig. 3(B)
Primer sequence
5′-GTCAGAATTCAGGGCTCAGCACA-3′ (forw)
5′-CTCAGGATCCAAAGTAAAAACGGTTT-3′ (rev)
5′-TACTGCAGACTGACCTAACTCGAGGAGG-3′ (forw)
5′-GCGGAATTCTATGGTACATGTCTTAAAATC-3′ (rev)
5′-CGTCGAATTCATCAAGCATCAT-3′ (forw)
5′-CGTGAAGCTTGGTTTTTTATTTTTAG-3′ (rev)
Primer sequence
5′-ATGTCTACCGTTCATGAAATTCT-3′ (forw)
5′-GTCAAAGCTTTCAGTCATCCCCACCA-3′ (rev)
Primer sequence
5′-TACTGCAGAGCCCCGCGACAGCCCAAGCA-3′ (forw)
5′-CGCGAATTCCCAACAGTAAAAATTCAG-3′ (rev)
5′-TAATACGACTCACTATAGGAGCCCCGCGACAGCCCAAGC-3′ (forw)
5′-TAAACTAACAAAAGAGCGGG-3′ (rev)
5′-TAATACGACTCACTATAGGGTTTCCTACGCATTACCTGG-3′ (forw)
5′-CCAACAGTAAAAATTCAGTT-3′ (rev)
5′-TAATACGACTCACTATAGGAGCCCCGCGACAGCCCAAGC-3′ (forw)
5′-AGCTGGAGCACGGAGCAG-3′ (rev)
5′-TAATACGACTCACTATAGGAACAGTTCTCCGCAGTCAGC-3′ (forw)
5′-TAAACTAACAAAAGAGCGGG-3′ (rev)
5′-TAATACGACTCACTATAGGAGCCCCGCGACAGCCCAAGC-3′ (forw)
5′-CCGCGGGCTGACTGC-3′ (rev)
5′-TAATACGACTCACTATAGGCTAACAGTTC-3′ (forw)
5′-GCTGACTGCGGA-3′ (rev)
5′-TAATACGACTCACTATAGGCTAACAGCCCCCTGT-3′ (forw)
5′-TAAACTAACAAAAGAGCGGG-3′ (rev)
3. The T7 promoter site is underlined.
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primers (Genosys) containing the T7 promoter site (underlined in Table 2B).
These transcripts were used directly for in vitro transcription.
2.8. In vitro transcription
RNA probes were uniformly [α-32P]UTP-labelled (3000 Ci/mmol; Amer-
sham Pharmacia Biotech) in vitro by transcription of linearised templates (Table
1) or PCR products (Table 2) for 90 min, by standard procedures as described in
the Promega protocol. A specific activity of 1.0–2.5×108 cpm/μg RNA was
obtained. Labelled RNA probes were analysed for integrity and purity by
agarose gel electrophoresis.
2.9. AnxA2–RNA binding assays
AnxA2–RNA binding assays were performed essentially as described by
Kwon and Hecht [34]. RNAwas incubated with AnxA2t or recombinant AnxA2
in RNA binding solution (10 mM triethanolamine, pH 7.4, 50 mM KCl, 1 mM
DTT, 2 mM MgSO4, 1 mM CaCl2 and 1 μg/μl of yeast tRNA), supplemented
with 20 U/ml RNasin (Promega) containing 2.5% (w/v) Ficoll for 20 min in a
final volume of 20 μl. After incubation, the RNA probes were covalently
crosslinked to the proteins by a 10 min exposure to UV light at 5 cm distance
using a Hoefer UVC 500. RNases T1 and Awere then added for 30 min at 37 °C
to a final concentration of 0.01 U/μl and 0.1 μg/μl, respectively, to digest
unprotected RNA. Nucleotide–protein complexes were separated from
degraded RNA probe by 10% (w/v) SDS-PAGE [33] and visualised using a
Canberra Packard Instant Imager. Coomassie Brilliant Blue staining was carried
out to verify the amount of protein loaded in each lane. The binding assays of the
competition experiments consisted of both radiolabelled and unlabelled
competitor RNA.Fig. 2. AnxA2 and c-myc mRNAs, but not β2-microglobulin mRNA, associate wi
products resolved on 1.8% (w/v) agarose gel stained with ethidium bromide
immunoprecipitated using monoclonal AnxA2 antibodies (α-AnxA2) coupled to Pro
and β2-microglobulin fragments in the isolated immunoprecipitates were then RT-PC
(lanes 3, 9 and 19) using anxA2-, c-myc- and β2-microglobulin-specific primers, res
immunoprecipitation with RAM-coated Protein A-Sepharose alone and RT-PCRs we
negative controls, the immunoprecipitated samples were either treated with RNase pri
present (lanes 2, 8 and 18). No β2-microglobulin fragment appeared after Mg
2+ titra
microglobulin primers and the RT-PCR reaction conditions in the presence of 2 mM
500 bp DNA size marker (lanes 1, 7 and 13) is indicated to the left. (B) Western blot a
absence (lane 21) or presence (lane 22) of AnxA2 monoclonal antibodies. AnxA2
coupled goat anti-mouse IgG. This secondary antibody also reacts with the heavy c3. Results
3.1. AnxA2 and c-myc mRNAs associate with CBP and AnxA2
in vivo
To identify the subpopulation of polysomes involved in
translation of anxA2 mRNA, polysomal sub-fractionations
were prepared from Krebs II cells [23,24] and Northern blot
analysis was performed. The results showed that anxA2
mRNA is highly enriched in the CBP (Fig. 1). β2-
microglobulin mRNA, translated on MBP, and c-myc
mRNA, translated on CBP of these cells, were used as
negative and positive controls, respectively [23–25]. Further,
to verify that AnxA2 interacts with c-myc and anxA2 mRNAs
in intact cells, AnxA2 was immunoprecipitated from the
cytoskeletal fraction of Krebs II cells, and RT-PCR of the
associated RNA was performed using specific primers for the
3′-UTR regions of these mRNAs. Whereas no amplification of
β2-microglobulin cDNA was observed (Fig. 2A, lanes 14–17),
this cDNA was efficiently amplified when total cellular RNA
was used (Fig. 2A, lane 20), indicating that the primers and
RT-PCR conditions were specific. By contrast, cDNA
fragments corresponding to the 3′-UTRs of anxA2 and c-
myc mRNAs were amplified (Fig. 2A, lanes 6 and 12,
respectively) and their identities were confirmed by sequenc-
ing (data not shown). The specificity of immunoprecipitationth cytoskeleton-bound mRNPs in Krebs II cells. (A) Amplified RT-PCR/PCR
. The AnxA2-bound mRNP complexes in the cytoskeleton fraction were
tein A-Sepharose via RAM (lanes 3, 4, 6, 9, 10, 12, 14–17). The anxA2, c-myc
R amplified (lanes 4, 6, 10, 12, 14–17) or, as a negative control, PCR amplified
pectively. As negative controls, the cytoskeleton fraction was also subjected to
re performed using the specific primers as indicated (lanes 5 and 11). As further
or to RT-PCR (lanes 4 and 10) or the RT-PCRs were performed with no template
tion of the RT-PCR reaction (lanes 14–17). Therefore, the specificity of the β2-
Mg2+ were verified using total RNA purified from Krebs II cells (lane 20). The
nalysis of the immunoprecipitates obtained from the cytoskeleton fraction in the
was detected using monoclonal primary AnxA2 antibodies followed by HRP-
hain (HC) of mouse IgG present in the immunoprecipitates.
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Western blot analysis (Fig. 2B). The latter showed that AnxA2
is present in the specific immunoprecipitates (lane 22), but not
in control precipitates containing rabbit anti-mouse IgG
(RAM) alone (lane 21). Similar results were obtained using
total lysates of Krebs II cells (data not shown), but as
expected, less mRNA was recovered in these immunopreci-
pitates, since only a fraction of the total cellular AnxA2 is
associated with mRNPs.Fig. 3. Mapping of the sequence elements of anxA2 mRNA involved in its binding to
in vitro from the full-length mRNA. The numbers to the left refer to the transcripts u
transcripts are shown in red. (B) The binding of 2 fmol (∼100000 cpm) of the radiola
(C) Schematic presentation of the different anxA2 3′-UTR transcripts generated in
binding assays shown in panel D. The AnxA2-binding transcripts are shown in red
indicated in (C) to 2 μg of purified recombinant AnxA2. (E) Prediction of metasta
revealed a putative stem–loop structure containing the AACAG sequence (boxed
Materials and methods.3.2. Sequence elements of anxA2 mRNA involved in its binding
to AnxA2
The above experiments established that AnxA2 interacts
with anxA2 mRNA in vivo. Moreover, we have recently shown
that it interacts directly with the localisation signal in the 3′-
UTR of c-mycmRNA [17]. To establish a direct mRNA-binding
and identify the region of anxA2 mRNA involved in AnxA2
binding, an UV cross-linking assay was used to monitor theAnxA2. (A) Schematic presentation of the different anxA2 transcripts generated
sed in the AnxA2–RNA binding assays shown in panel B. The AnxA2-binding
belled transcripts indicated in (A) to 2 μg of AnxA2t or BSA (lane to the right).
vitro. The numbers to the left refer to the transcripts used in the AnxA2–RNA
. (D) The binding of 150 fmol (∼100000 cpm) of the radiolabelled transcripts
ble secondary structures (Mfold programme) of the Δ1075–1149 nt transcript
region). The AnxA2–RNA binding reactions were performed as described in
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(Fig. 3A and C). As shown in Fig. 3B, full-length mRNA
(transcript 1), as well as the Δ1–964 nt (transcript 2) and the
Δ473–1381 nt (transcript 4) transcripts, overlapping in the
coding region, were all found to bind to AnxA2t purified from
porcine intestinal epithelial cells. By contrast, transcript 3,
corresponding to the coding region of the anxA2 mRNA (Δ55–
1074 nt) (Fig. 3B) and the Δ473–964 nt transcript (Fig. 3B,
transcript 5), corresponding to the coding region of transcript 4,
do not interact with AnxA2. Thus, comparison of the binding
activities of the different anxA2 transcripts indicated that a
binding motif resides in the 3′-UTR (Fig. 3B, compare
transcripts 3 and 5 with transcript 4). This conclusion was
further supported by the binding of transcript 6 (Δ1075–
1381 nt) to AnxA2 (Fig. 3D).
Comparison of the coding region transcript 3 (Δ55–1074 nt)
with the partly overlapping Δ1–964 nt transcript (Fig. 3B,
compare transcripts 2 and 3), suggested that an additional
binding region may reside in the 55 nt 5′-UTR of anxA2
mRNA. However, we were unable to confirm this by binding of
the radiolabelled anxA2 Δ1–55 nt transcript to its cognate
protein, presumably because of loss of a particular secondaryFig. 4. Competition experiments provide evidence that AnxA2 binds to two separate
with the Δ1124–1224 nt region of the anxA2 3′-UTR (C). (A) Increasing amounts (
anxA2 mRNA (lanes 1–4) or anxA2 3′UTR (lanes 5–8) as indicated above the figure
full-length anxA2 transcript as indicated below the figure. (B) 2 μg of AnxA2t was
absence (control, lane 9) or presence of 1 μg of either poly(rA), poly(rU), poly(rC) o
complex secondary structures. (C) Increasing amounts (10-, 100- or 500-fold molar e
transcript (lanes 5–8), orΔ1150–1224 nt transcript (lanes 9–13) were added to 2 μg o
radiolabelled transcripts. (D) The unlabelled Δ1124–1224 nt transcript was either ex
with 50 fmol of the uniformly radiolabelled Δ1075–1149 nt (lanes 13 and 14) and Δ
inhibit non-specific RNA binding in all reactions. Binding was performed as descristructure present in the longer RNA transcripts (data not
shown). No anxA2 mRNA binding was observed when BSA
was used in the UV cross-linking assays (Fig. 3B, lane to the
right).
Since our previous results showed that AnxA2 interacts with
the 3′-UTR of c-myc mRNA [17] and the present study shows
that it also interacts with that of its cognate mRNA (Fig. 3B), it
was of interest to map the binding region in the 3′-UTR of
anxA2 mRNA in more detail. Different transcripts of the 3′-
UTR of the anxA2 mRNA were generated by PCR using
specific primers and subsequent in vitro transcription of the
PCR fragments (Fig. 3C). The Δ1075–1381 nt (the entire 3′-
UTR) and the Δ1075–1224 nt transcripts, but not the Δ1225–
1381 nt transcript, were found to bind to AnxA2, indicating the
presence of a binding site in the 5′ end of the anxA2 3′-UTR
(Fig. 3D, compare transcripts 6, 7 and 8). The difference
between the non-bindingΔ1075–1123 nt (Fig. 3D, transcript 9)
and the AnxA2-binding Δ1075–1149 nt 3′-UTR region (Fig.
3D, transcript 11) is a short sequence of 26 nt, which may form a
stem–loop structure (Fig. 3E, boxed region), as determined
using the algorithms of the Mfold programme [35,36].
Therefore, this short nucleotide sequence could be involved inregions of the anxA2 mRNA (A), to both ssRNA and dsRNA (B) and interacts
10-, 50- or 100-fold molar excess) of unlabelled in vitro transcribed full-length
were added to 2 μg AnxA2t to compete with 1 fmol of uniformly radiolabelled
incubated with 2 fmol of radiolabelled in vitro transcribed anxA2 mRNA in the
r poly(rI-rC) (lanes 10–13). Note that poly(rG) was not included as it may form
xcess) of the unlabelled Δ1124–1224 nt transcript (lanes 1–4), Δ1075–1149 nt
f recombinant AnxA2 to compete with 150 fmol of the corresponding uniformly
cluded or added in 500-fold excess to 2 μg of recombinant AnxA2 to compete
1150–1224 nt (lanes 15 and 16) transcripts. 1 μg/μl yeast tRNAwas present to
bed in Materials and methods.
Fig. 5. The effect of increasing KCl concentration on the binding of anxA2
mRNA to its cognate protein. 2 fmol of radiolabelled in vitro transcribed anxA2
mRNAwas incubated with 2 μg AnxA2t in the presence of 50 (lane 1), 100 (lane
2), 200 (lane 3) or 500 (lane 4) mMKCl. Binding was performed as described in
Materials and methods.
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corroborated by the finding that the Δ1150–1224 nt transcript
(Fig. 3D, transcript 13) interacted with AnxA2 more weakly
than the Δ1124–1224 nt transcript (Fig. 3D, transcript 10).
However, a transcript corresponding to this short 26 nt sequence
was not able to bind to AnxA2 (Fig. 3D, transcript 12).
To further examine whether anxA2 mRNA contains two
separate AnxA2 binding sites, competition experiments were
conducted in which unlabelled full-length anxA2 mRNA and
its 3′-UTR competed with the radiolabelled full-length anxA2
mRNA transcript for binding to AnxA2 (Fig. 4A). Effective
competition was observed at 100-fold molar excess of
unlabelled anxA2 mRNA (Fig. 4A, lane 4). By contrast, the
unlabelled 3′-UTR transcript did not significantly compete with
the full-length anxA2 mRNA (Fig. 4A, lanes 5–8), suggesting
that the mRNA contains two independent AnxA2 binding
regions. Further competition experiments, using radiolabelled
anxA2 mRNA, were performed with ssRNA or dsRNA of
random size (Fig. 4B, lanes 9–13). The results suggested that
ssRNA homopolymers are more efficient competitors than the
poly(rI-rC) dsRNA. Poly(rG) was not tested as G-rich
sequences are known to form complex secondary structures
[37]. On average (mean values from 3 independent experi-
ments), mRNA binding to AnxA2 was reduced to 41±2%, 24±
4%, 36±4% and 67±5% of the control values when the binding
of radiolabelled anxA2 mRNA was competed by the
presence of ss poly(rA), ss poly(rU), ss poly(rC) and ds
poly(rI-rC) homopolymers, respectively. These data support
the conclusion that the AnxA2-binding region of the anxA2Fig. 6. Alignment of partial 3′-UTR regions of anxA2mRNAs from different mamma
are indicated in grey. The numbers above refer to the nucleotide sequence of bovinemRNA has both ss and ds character, with a possible weak
preference for U-rich sequences. However, complete com-
petition was not observed with any of the homopolymers,
indicating that specific higher order mRNA structures are
involved in the AnxA2–mRNA complex formation. The
presence of uridine in the AnxA2-binding region was also
supported by the UV cross-linking experiments in which the
signal observed on instant imaging, is due to the UV cross-
linked [32P]-labelled uridine nucleotides bound to AnxA2.
Since the relative electrophoretic mobility of nucleotide-
bound AnxA2 did not significantly change, it appears that
only a few nucleotides could be UV cross-linked to AnxA2
(data not shown).
To obtain further information on the identity of the specific
AnxA2-binding 3′-UTR region of the anxA2 mRNA, additional
competition experiments were performed. Thus, in these
experiments three different unlabelled transcripts of the 1075–
1224 nt 3′-UTR region of anxA2 mRNA (transcripts 10, 11 and
13) were used at 10-, 100- and 500-fold molar excess, to
compete with the corresponding radiolabelled transcripts (Fig.
4C). It is evident that only the Δ1124–1224 nt transcript
(transcript 10) competed effectively (Fig. 4C, lanes 1–4),
suggesting that most of this region is required for specific
interaction with AnxA2. The finding that the unlabelled
Δ1124–1224 nt transcript (transcript 10) was also able to
compete for the binding of the radiolabelled Δ1075–1149 nt
(transcript 11) and Δ1150–1224 nt (transcript 13) transcripts
(Fig. 4D, lanes 13–14 and 15–16, respectively), further support
this conclusion.
High concentrations of KCl completely abolished the
binding of anxA2 mRNA to the AnxA2t (Fig. 5), indicating
that electrostatic interactions are crucial for the interaction.
These forces are most likely contributed by basic amino acids
and the phosphate backbone of RNA [38]. The interaction was
preserved at physiological KCl concentrations.
To compare the 3′-UTRs of anxA2 mRNA in different
mammalian species, an alignment of the nucleotide sequences
was performed (Fig. 6). In agreement with the binding data,
showing that the 86 nt localisation signal of mouse c-myc
mRNA [17] and the 1124–1224 nt region of anxA2 mRNA
(present results) are involved in interaction with AnxA2, a five
nucleotide consensus sequence, 5′-AA(C/G)(A/U)G, could be
identified in these regions (Fig. 6). This sequence is repeatedlian species and mouse c-mycmRNA. The two repeats of the consensus sequence
anxA2 mRNA.
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mRNA, whereas the repeat in the mouse and rat sequences
appears to be degenerated. Moreover, the 3′-UTRs of anxA2
mRNAs contain a common sequence, CCAG, which is not
present in the localisation signal of c-myc mRNA (Fig. 6, in
bold). It appears to be unrelated to the interaction with AnxA2
since it is located in the non-binding Δ1075–1123 nt region.
However, it could represent a cis-acting sequence for another
trans-acting factor.
4. Discussion
4.1. The interaction of AnxA2 with its cognate mRNAs involves
the 3′-UTR
We have previously shown that AnxA2 is a mRNA-binding
protein associated with CBP of Krebs II cells [15]. This finding
indicated that specific AnxA2-associated mRNAs are bound to
cytoskeleton elements and translated on CBPs. One of these
specific mRNAs is c-myc [24], which binds to AnxA2 via the
localisation signal in its 3′-UTR [17]. The presence of c-myc
mRNA in AnxA2-containing mRNP complexes has been
confirmed by an independent study [16].
In the present study we show that AnxA2 interacts with
specific mRNAs in the CBP fraction and identify two such
mRNAs as anxA2 and c-myc mRNAs (Figs. 1 and 2).
Immunoprecipitation of AnxA2 from cell fractions, followed
by RT-PCR of the AnxA2-associated RNAs using specific
primers, revealed that these mRNAs, but not β2-microglobulin
mRNA, are present in the AnxA2-associated mRNP complexes
(Fig. 2), indicating that this interaction is specific for a subset of
cellular mRNAs. These results are in accordance with recent
data showing that structurally and/or functionally related
mRNAs are transported together in large mRNP complexes
[39]. The localisation signal in the AnxA2-binding 3′-UTR of c-
myc mRNA [17], forms a stem–loop structure that targets the
mRNA to CBP in the perinuclear region for translation [40,41].
Also anxA2 mRNA is translated on CBP (Figs. 1 and 2),
suggesting that it contains a similar stem–loop structure in its
3′-UTR.
To identify the sequence elements in anxA2 mRNA involved
in its binding to AnxA2, several truncated forms of anxA2
mRNAwere generated. Collectively, the in vitro binding studies
(Figs. 3B and 4A) suggest the presence of two independent
binding regions in full-length anxA2 mRNA. One such region
resides in the 3′-UTR and another possibly in the 5′-UTR,
enabling AnxA2 to interact with both regulatory ends of the
mRNA. UTRs at both termini of mRNA are known to interact
via associated proteins such as poly(A)-binding protein and
initiation factor 4G [42,43]. Furthermore, by binding to trans-
acting proteins, the 5′-UTR is mainly involved in modulating
initiation of translation, while the 3′-UTR is primarily involved
in mRNA transport and stability [44]. AnxA2 does not seem to
play a role in mRNA stability since binding of AnxA2 to c-myc
mRNA or its cognate mRNA in cell lysates has no effect on
mRNA degradation in vitro (unpublished results). Translation is
repressed during mRNA transport to ensure specific targeting ofproteins. Thus, it is possible that AnxA2 functions in both
localisation and repression of translation during transport of
specific mRNAs.
Further binding studies, using different short truncated
transcripts of the 3′-UTR, indicated that the 1124–1224 nt
region of anxA2 mRNA is involved in the binding to its cognate
protein (Fig. 3C and D, compare transcripts 9–13). Competition
studies corroborate this proposal since only the entire 1124–
1224 nt transcript (transcript 10) was able to compete for the
other AnxA2-binding transcripts (transcripts 11 and 13) of the
3′-UTR of anxA2 mRNA (Fig. 4D). The interaction with
AnxA2 appeared to essentially involve the 1124–1149 nt
region, which may form a putative stem–loop structure,
although a short transcript corresponding to this region was
not able to bind to AnxA2 (Fig. 3D, transcript 12), most likely
due to its inability to form a particular higher order structure or
due to the formation of an equilibrium of metastable RNA
structures of low energy. Interestingly, this short region contains
a putative binding motif of five nucleotides, 5′-AA(C/G)(A/U)
G, that appears twice within this 100 nt sequence (Δ1124–
1224 nt transcript) (Fig. 6) and most likely is part of a specific
higher order RNA structure. The Δ1150–1224 nt transcript
(transcript 13) that interacts only weakly with AnxA2 contains
only the second repeat, suggesting that the first one in the
Δ1124–1149 nt region represents the principal AnxA2-binding
region. However, the second repeat may also contribute to the
interaction since the Δ1124–1224 nt transcript (transcript 10) is
able to compete for theΔ1075–1149 nt transcript (transcript 11)
(Fig. 4D). Repeated binding motifs have been implicated in the
targeting of other mRNAs such as Vg1 or VegT [45]. In general,
most perinuclear mRNA localisation signals have been
delimited to 100–200 nt [28,40,46] and the signal in the 3′-
UTR of anxA2 mRNA appears to be of the same size. Notably,
the five-nucleotide consensus sequence (AACAG) is also
present in the 86 nt localisation signal of mouse c-myc
mRNA, which was previously found to interact with AnxA2
[17]. Furthermore, the perinuclear localisation signal in the 3′-
UTR of vimentin mRNA [46] that is translated on CBP
(unpublished results), contains two repeats of this consensus
sequence. However, the perinuclear localisation signals of the
mouse slow/cardiac troponin C and chicken α-cardiac actin
mRNAs [47] lack this sequence, suggesting that it may target
mRNAs to CBP, outside the perinuclear region.
Several lines of evidence support the conclusion that the
interaction of AnxA2 with anxA2 and c-mycmRNAs is specific.
Firstly, β2-microglobulin mRNA was not associated with
immunoprecipitated AnxA2 (Fig. 2A). Secondly, AnxA2 does
not bind to the coding region of its cognate mRNA nor to the
Δ1075–1123 nt, Δ1122–1143 nt or Δ1225–1381 nt transcripts
(transcripts 9, 12 and 8, respectively) of the 3′-UTR. Thirdly, the
binding is not caused by non-specific mRNA–AnxA2 interac-
tions since BSA (Fig. 3), recombinant p11, α-actin and
denatured AnxA2 did not show any binding (data not shown).
Finally, a high concentration of tRNA (1 μg/μl) was present in
the binding assays to prevent non-specific RNA–protein
interactions and we have previously reported that AnxA2 does
not bind rRNA [15].
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RNA structures
Using the Mfold programme we were not able to predict an
identical RNA secondary structure either for the aligned
sequences shown in Fig. 6 or the entire 3′-UTR of the same
mRNAs. Also, previous prediction of secondary structures in
c-myc mRNA from several species failed to identify identical
stem–loop structures, regardless of a rather long consensus
sequence [40]. However, both rat and mouse anxA2 mRNAs
interact with AnxA2 (unpublished results), indicating that a
specific secondary structure of the 3′-UTR is required for
binding. In favour of this suggestion, mutating the GUAUUUA
sequence in the localisation signal of c-myc mRNA, leading to
disruption of a secondary stem–loop structure, also partially
abolished its interaction with AnxA2 [17]. Moreover, the
presence of 30% (v/v) formamide in the binding assay, which
destroys secondary structures in mRNA, greatly diminished
their binding to AnxA2, while Mg2+, which promotes the
formation and stabilisation of RNA secondary structures,
enhanced the binding (data not shown).
Previous well-known RNA–protein interactions have been
demonstrated to rely mainly upon higher order structures [48].
For example, mutations disrupting the formation of the stem–
loop structure in the localisation signal in the 3′-UTR of K10
mRNA all block its localisation to the anterior pole of the
Drosophila oocyte. By contrast, mutations that alter only the
nucleotide sequence have little or no effect on the localisation of
this mRNA [49]. In the present study, competition with both
ssRNA or dsRNA polymers partially inhibited the binding of
both full-length anxA2 (Fig. 4B) and c-myc mRNAs (unpub-
lished results) to AnxA2, with the ssRNA homopolymers being
the most effective competitors. Thus, the binding of these
mRNAs to AnxA2 appears to involve their higher order
structure including both ssRNA and dsRNA regions.
Based on these results, we conclude that cells contain a
distinct pool of AnxA2 that is an integral component of
mRNP complexes associated with the cytoskeleton, and
suggest that it functions in the transport and targeting of
specific mRNAs. This proposal is further supported by the
demonstration that AnxA2 also acts as a nuclear shuttle
protein [50,51] and that it binds to the localisation signal of
c-myc mRNA [17], which is translated on CBP [15].
Importantly, the present results indicate that a region of
about 100 nucleotides in the 3′-UTR of anxA2 mRNA is
involved in the interaction with its cognate protein. This
region contains a specific higher order RNA structure and
two repeats of a five nucleotide consensus sequence, 5′-AA
(C/G)(A/U)G. The interaction of AnxA2 with its cognate
mRNA may imply a post-transcriptional feed-back mecha-
nism that ultimately regulates the synthesis of the protein.
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